Dova Pharmaceuticals, Inc.·4

Jul 7, 6:44 AM ET

Dova Pharmaceuticals, Inc. 4

4 · Dova Pharmaceuticals, Inc. · Filed Jul 7, 2017

Insider Transaction Report

Form 4
Period: 2017-07-05
Sapir Alex
DirectorPresident & CEO
Transactions
  • Purchase

    Common Stock

    2017-07-05$17.00/sh+20,100$341,70020,100 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION